Molecular pathology-integrated clinicopathological prognostic factors

J Chin Med Assoc. 2023 Mar 1;86(3):262-264. doi: 10.1097/JCMA.0000000000000872. Epub 2023 Jan 4.

Authors

Szu-Ting Yang^{1

2

3}, Chia-Hao Liu^{1

2

3}, Peng-Hui Wang^{1

2

3

4}

Affiliations

¹ Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
² Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
³ Female Cancer Foundation, Taipei, Taiwan, ROC.
⁴ Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, ROC.

PMID: 36728438
DOI: 10.1097/JCMA.0000000000000872

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor*
Pathology, Molecular*
Prognosis
Risk Factors

Substances

Biomarkers, Tumor